Market News for Merck & Co Inc (MRK)
Merck (NYSE:MRK) stock is up 5% to trade at $121.75, after the blue-chip pharma giant received the "go ahead" from European officials in regard to its combination of the company's products, Keytruda and Padcev, for a lower risk form of bladder cancer treatment....
Schaeffers Research - 5/22/2026 10:51:06 AM
More News for MRK
Stock Analysis for MRK
Related Stocks:
Sichuan Kelun-Biotech Biopharmaceutical said on Thursday its experimental treatment combined with partner Merck's Keytruda improved survival rate in patients with advanced lung cancer, meeting the main goal of a late-stage study....
Reuters - 5/21/2026 5:06:03 PM
More News for MRK
Stock Analysis for MRK
Related Stocks:
